A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

Paulus, Walter J., Tschöpe, Carsten·2013·Journal of the American College of Cardiology

Cited by (1,005)

Items 701–800 of 1,005

  1. Risk factors for heart failure are associated with alterations of the LV end-diastolic pressure–volume relationship in non-heart failure individuals: data from a large-scale, population-based cohort
    Michael Schwarzl, Francisco Ojeda, Tanja Zeller, Moritz Seiffert, Peter Moritz Becher, Thomas F. Münzel, Philipp Sebastian Wild, Maria Blettner, Karl Johannes Lackner, Norbert Pfeiffer et al. · 2016 · European Heart Journal
  2. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure
    Sayma Sabrina Khanam, Jung‐Woo Son, Jun‐Won Lee, Young Jin Youn, Junghan Yoon, Seung‐Hwan Lee, Jang‐Young Kim, Sung Gyun Ahn, Min‐Soo Ahn, Byung‐Su Yoo · 2017 · BMC Cardiovascular Disorders
  3. Geriatric Nutritional Risk Index Predicts Cardiovascular Events in Patients at Risk for Heart Failure
    Masatoshi Minamisawa, Takashi Miura, Hirohiko Motoki, Yasushi Ueki, Hitoshi Nishimura, Kunihiko Shimizu, Wataru Shoin, Mikiko Harada, Tomoaki Mochidome, Keisuke Senda et al. · 2017 · Circulation Journal
  4. Long-term effect of critical illness after severe paediatric burn injury on cardiac function in adolescent survivors: an observational study
    Gabriel Hundeshagen, David Newcomb Herndon, Robert Patrick Clayton, Paul Wurzer, Alexis L. McQuitty, Kristofer Jennings, Ludwik Krzysztof Branski, Vanessa N. Collins, Nicole Ribeiro Marques, Celeste C. Finnerty et al. · 2017 · The Lancet Child & Adolescent Health
  5. Comorbidity in chronic obstructive pulmonary disease and cardiovascular disease
    Aleksey Michailovich Chaulin, Dmitry Viktorovich Duplyakov · 2021 · CARDIOVASCULAR THERAPY AND PREVENTION
  6. Sex Differences in Molecular Mechanisms of Cardiovascular Aging
    Vanessa Dela Justina, Jéssica Silva Miguez, Fernanda B.M. Priviero, Jennifer C. Sullivan, Fernanda R. C. Giachini, R. Clinton Webb · 2021 · Frontiers in Aging
  7. ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress
    Joseph Adu‐Amankwaah, Gabriel Komla Adzika, Adebayo Oluwafemi Adekunle, Marie Louise Ndzie Noah, Richard Mprah, Aisha Bushi, Nazma Akhter, Fei Huang, Yaxin Xu, Seyram Yao Adzraku et al. · 2021 · Frontiers in Cell and Developmental Biology
  8. NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
    James P. Teuber, Kobina Essandoh, Scott L. Hummel, Nageswara R. Madamanchi, Matthew J. Brody · 2022 · Antioxidants
  9. Discovery of Titin and Its Role in Heart Function and Disease
    Henk L. M. Granzier, Siegfried Labeit · 2025 · Circulation Research
  10. Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus
    Takayuki Kawata, Masao Daimon, Sakiko Miyazaki, Ryoko Ichikawa, Masaki Maruyama, Shuo-Ju Chiang, Chiharu Ito, Fumihiko Sato, Hirotaka Watada, Hiroyuki Daida · 2015 · Cardiovascular Diabetology
  11. Left ventricular diastolic function in relation to the urinary proteome: A proof-of-concept study in a general population
    Zhen‐Yu Zhang, Jan Albert Staessen, Lutgarde Thijs, Yumei Gu, Yan-Ping Liu, Lotte Jacobs, Thomas Koeck, Petra Zürbig, Harald Mischak, Tatiana Kuznetsova · 2014 · International Journal of Cardiology
  12. Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEF
    Carsten Tschöpe, Sophie Van Linthout, Frank Spillmann, Oliver Klein, Sebastian Biewener, Andrew B Remppis, David D. Gutterman, Wolfgang Albrecht Linke, Burkert Mathias Pieske, Nazha Hamdani et al. · 2015 · International Journal of Cardiology
  13. Heart Failure, Left Ventricular Remodeling, and Circulating Nitric Oxide Metabolites
    Julio A. Chirinos, Scott R. Akers, Lien Trieu, Harry Ischiropoulos, Paschalis‐Thomas Doulias, Ali Tariq, Izzah Vasim, Maheswara Reddy Koppula, Amer Ahmed Syed, Haideliza Soto‐Calderon et al. · 2016 · Journal of the American Heart Association
  14. Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study
    Kunihiro Matsushita, Lucia Kwak, Yingying Sang, Shoshana H. Ballew, Hicham Skali, Amil M. Shah, Josef Coresh, Scott David Solomon · 2017 · Journal of the American Heart Association
  15. Early-onset preeclampsia predisposes to preclinical diastolic left ventricular dysfunction in the fifth decade of life: An observational study
    Anouk Bokslag, Constantijn Franssen, Lisa J. Alma, Igor Kovačević, Floortje van Kesteren, Pim W. Teunissen, Otto Kamp B, Wessel Ganzevoort, Peter Lodewijk Hordijk, Christianne J.M. de Groot et al. · 2018 · PLoS ONE
  16. Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction
    Gilman D. Plitt, Jordan T. Spring, Michael J. Moulton, Devendra K. Agrawal · 2018 · Expert Review of Cardiovascular Therapy
  17. Left Ventricular Diastolic Myocardial Stiffness and End-Diastolic Myofibre Stress in Human Heart Failure Using Personalised Biomechanical Analysis
    Zhinuo Jenny Wang, Vicky Y. Wang, Chris P. Bradley, Martyn Peter Nash, Alistair A. Young, Jie Jane Cao · 2018 · Journal of Cardiovascular Translational Research
  18. ASSOCIATION OF RETINAL VEIN OCCLUSION WITH CARDIOVASCULAR EVENTS AND MORTALITY
    Chris Y. Wu, Tanawan Riangwiwat, Nath Limpruttidham, Pattara Rattanawong, Richard B. Rosen, Avnish A. Deobhakta · 2019 · Retina
  19. Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies
    Marijana Vaso Tadic, Cesare Cuspidi, Sven Plein, Evgeny Belyavskiy, Frank R. Heinzel, Maurizio Galderisi · 2019 · Journal of Clinical Medicine
  20. Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure
    Michele Correale, Stefania Paolillo, Valentina Mercurio, Giuseppe Limongelli, Francesco Barillà, Gaetano M. Ruocco, Alberto Palazzuoli, Domenico Scrutinio, Rocco Lagioia, Carolina Lombardi et al. · 2019 · European Journal of Internal Medicine
  21. Epicardial Fat Expansion in Diabetic and Obese Patients with Heart Failure and Preserved Ejection Fraction—A Specific HFpEF Phenotype
    Elsanhoury, Ahmed, Nelki, Vivian, Kelle, Sebastian, Van Linthout, Sophie, Tschöpe, Carsten · 2021 · Frontiers in Cardiovascular Medicine
  22. Therapeutic opportunities for senolysis in cardiovascular disease
    Mark D. Sweeney, Stuart A. Cook, Jesús Gil · 2022 · FEBS Journal
  23. Heart Failure With Preserved Ejection Fraction With CKD: A Narrative Review of a Multispecialty Disorder
    Rahul Patel, Akash Sharma, Anand Prasad, Shweta Bansal · 2023 · Kidney Medicine
  24. High-intensity interval training attenuates endothelial dysfunction in a Dahl salt-sensitive rat model of heart failure with preserved ejection fraction
    Volker Adams, Márcia Netto Magalhães Alves, Tina Fischer, Natale P. L. Rolim, Sarah Werner, Nicole Schütt, Thomas Scott Bowen, Axel Hans-Peter Linke, Gerhard C Schuler, Ulrik Wisløff · 2015 · Journal of Applied Physiology
  25. Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis
    Efstathios Kastritis, Ioannis Papassotiriou, Evangelos Terpos, Μαρία Ρούσσου, Maria Gavriatopoulou, Anna Komitopoulou, Chrysanthi L. Skevaki, Evangelos Eleutherakis‐Papaiakovou, Constantinos Pamboucas, Erasmia Psimenou et al. · 2016 · Blood
  26. Clinical significance of noninvasive coronary flow reserve assessment in patients with ischemic heart disease
    Viviany R. Taqueti, Marcelo F. Di Carli · 2016 · Current Opinion in Cardiology
  27. Exercise training reverses age‐induced diastolic dysfunction and restores coronary microvascular function
    Kazuki Hotta, Bei Chen, Bradley Jon Behnke, Payal Ghosh, John N. Stabley, Jeremy A. Bramy, Jaime L. Sepulveda, Michael D. Delp, Judy Marie Muller‐Delp · 2017 · The Journal of Physiology
  28. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function
    Nishant R. Shah, Michael K. Cheezum, Vikas Veeranna, Stephen James Horgan, Viviany R. Taqueti, Venkatesh Locharla Murthy, Courtney R. Foster, Jon Mark Hainer, Karla M. Daniels, Jose Rivero et al. · 2017 · Journal of the American Heart Association
  29. Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases
    João Bessa, António Albino‐Teixeira, Marta Reina‐Couto, Teresa Sousa · 2020 · Clinica Chimica Acta
  30. Targeting fibrosis in the failing heart with nanoparticles
    Fabiana Passaro, Carlo Gabriele Tocchetti, Gaia Spinetti, Francesca Paudice, Luigi Ambrosone, Ciro Costagliola, Francesco Cacciatore, Pasquale Abete, Gianluca Testa · 2021 · Advanced Drug Delivery Reviews
  31. Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation
    Jonathan Ariyaratnam, Adrian D. Elliott, Ricardo Sadashi Mishima, Celine Gallagher, Dennis H. Lau, Prashanthan Sanders · 2021 · Heart Rhythm O2
  32. Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
    Husam M. Salah, Subodh Verma, Carlos G. Santos‐Gallego, Ankeet S. Bhatt, Muthiah Vaduganathan, Muhammad Shahzeb Khan, Renato D. Lópes, Subhi Jamal Alaref, Darren K. McGuire, Marat Fudim · 2022 · Journal of Cardiovascular Translational Research
  33. The effect of SGLT2 inhibitors on the endothelium and the microcirculation: from bench to bedside and beyond
    Kyriakos S. Dimitriadis, Eleni Adamopoulou, Nikolaos Pyrpyris, Athanasios Sakalidis, Ioannis Leontsinis, Eleni Manta, Emmanouil Mantzouranis, Eirini Beneki, Στέργιος Σουλαϊδόπουλος, D. Konstantinidis et al. · 2023 · European Heart Journal - Cardiovascular Pharmacotherapy
  34. Eicosanoid and eicosanoid-related inflammatory mediators and exercise intolerance in heart failure with preserved ejection fraction
    Emily S. Lau, Athar Roshandelpoor, Shahrooz Zarbafian, Dongyu Wang, James Sawalla Guseh, Norrina B. Allen, Vinithra Varadarajan, Matthew Gregory Nayor, Ravi V. Shah, João A.C. Lima et al. · 2023 · Nature Communications
  35. Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential
    Oveena Fonseka, Sanskruti Ravindra Gare, Xinyi Chen, Jiayan Zhang, Nasser hawimel o Alatawi, Claire Ross, Wei Liu · 2025 · Cells
  36. The Role of Inflammation in the Pathophysiology of Heart Failure
    Mohammed Amara, Ohad Stoler, Edo Y. Birati · 2025 · Cells
  37. Enhanced endothelium epithelial sodium channel signaling prompts left ventricular diastolic dysfunction in obese female mice
    Guanghong Jia, Javad Habibi, Annayya Rao Aroor, Michael A. Hill, Vincent Gerard DeMarco, Li E. Lee, Lixin Ma, Brady J. Barron, Adam T. Whaley‐Connell, James R. Sowers · 2017 · Metabolism
  38. Effect of Serum Albumin Levels in Patients With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial)
    Stuart B. Prenner, Anupam Kumar, Lei Zhao, Mary Ellen Cvijic, Michael Basso, Thomas E. Spires, Zhuyin Li, Melissa Yarde, Priyanka Bhattacharya, Payman L. Zamani et al. · 2019 · The American Journal of Cardiology
  39. Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator
    Detmar Kolijn, Árṕad Kov́acs, Melissa Herwig, Mária Lódi, Marcel Sieme, Abdulatif Al Haj, Peter Sandner, Zoltán Papp, H. Peter Reusch, Peter Lukas Haldenwang et al. · 2020 · Frontiers in Physiology
  40. Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
    Packer, Milton, Zile, Michael R., Kramer, Christopher M., Murakami, Masahiro, Ou, Yang, Borlaug, Barry A. · 2025 · Journal of the American College of Cardiology
  41. Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction
    Marco Guazzi, Robert Naeije · 2021 · Circulation Heart Failure
  42. Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF
    Leanne Mooney, Nathaniel Mark Hawkins, Pardeep S. Jhund, Margaret M. Redfield, Muthiah Vaduganathan, Akshay Suvas Desai, Jean Lucien Rouleau, Masatoshi Minamisawa, Amil M. Shah, Martin P. Lefkowitz et al. · 2021 · Journal of the American Heart Association
  43. Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis
    Joanna M Bilak, Uazman Alam, Chris Miller, Gerry Patrick McCann, Jayanth Ranjit Arnold, Prathap Kanagala · 2022 · Cardiac failure review
  44. JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
    Takeshi Kitai, Shun Kohsaka, Takao Kato, Eri Toda Kato, Kimi Sato, KANAKO TERAMOTO, Hidenori Yaku, Eiichi Akiyama, Masahiko Ando, Chisato Izumi et al. · 2025 · Journal of Cardiac Failure
  45. The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction
    Carolina Janssen-Telders, Etto C. Eringa, Joris R. de Groot, Frances S. de Man, M. Louis Handoko · 2025 · Cardiovascular Research
  46. Interleukin-6 Signaling, Soluble Glycoprotein 130, and Inflammation in Heart Failure
    Erik Tandberg Askevold, Lars Lysgaard Gullestad, Christen Peder Dahl, Arne Yndestad, Thor Ueland, Pål Aukrust · 2014 · Current Heart Failure Reports
  47. Soluble Tumor Necrosis Factor Receptors and Heart Failure Risk in Older Adults
    Catherine Norton Marti, Hassan Khan, Douglas L. Mann, Vasiliki V. Georgiopoulou, Kirsten B. Bibbins-Domingo, Tamara B. Harris, Annemarie Koster, Anne B. Newman, Stephen B. Kritchevsky, Andreas P. Kalogeropoulos et al. · 2013 · Circulation Heart Failure
  48. Characteristics and Course of Heart Failure Stages A–B and Determinants of Progression – design and rationale of the STAAB cohort study
    Martin Wagner, Theresa Tiffe, Caroline Morbach, Götz Gelbrich, Stefan Störk, Peter Ulrich Heuschmann · 2016 · European Journal of Preventive Cardiology
  49. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities
    Yochai Adir, Marco Guazzi, Offer Amir, Pier Luigi Temporelli, Antonia Cannito, Stefano Ghio · 2017 · American Heart Journal
  50. Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study
    Javed Butler, Andreas P. Kalogeropoulos, Kevin Joseph Anstrom, Priscilla Y. Hsue, Raymond J. Kim, Rebecca Scherzer, Sanjiv Jayendra Shah, Svati Hasmukh Shah, Eric J. Velazquez, Adrian F. Hernandez et al. · 2018 · Journal of Cardiac Failure
  51. Transcriptomics of cardiac biopsies reveals differences in patients with or without diagnostic parameters for heart failure with preserved ejection fraction
    Sarbashis Das, Christoffer Frisk, Maria J. Eriksson, Anna Walentinsson, Matthias Corbascio, Camilla Hage, Chanchal Kumar, Michaela Asp, Joakim Lundeberg, Eva Maret et al. · 2019 · Scientific Reports
  52. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
    Adrian Ignacio Loffler, Jonathan A. Pan, Pelbreton C. Balfour, Peter W. Shaw, Yang Yang, Moiz Nasir, Daniel A. Auger, Frederick H. Epstein, Christopher M. Kramer, Li‐Ming Gan et al. · 2019 · The American Journal of Cardiology
  53. Statins Reverse Postpartum Cardiovascular Dysfunction in a Rat Model of Preeclampsia
    Kristin Kräker, Jamie M. O’Driscoll, Till Schütte, Florian Herse, Olga V. Patey, Michaela Golić, Sabrina Geisberger, Stefan Verlohren, Anna Birukov, Arnd Heuser et al. · 2019 · Hypertension
  54. Mitochondrial Dysfunction and Inflammaging in Heart Failure: Novel Roles of CYP-Derived Epoxylipids
    Hedieh Keshavarz-Bahaghighat, Ahmed M. Darwesh, Deanna K. Sosnowski, John M. Seubert · 2020 · Cells
  55. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling
    Lindsey Dugaucquier, Eline Feyen, Ligia Monica Mateiu, Tine Bruyns, Gilles W. De Keulenaer, Vincent F. M. Segers · 2020 · American Journal of Physiology-Heart and Circulatory Physiology
  56. Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction
    John Elsby Sanderson, Fang Fang, Mi Lu, Yao Chen, Yong Xiang Wei · 2020 · Heart
  57. Altered Metabolic Profile With Sodium-Restricted Dietary Approaches to Stop Hypertension Diet in Hypertensive Heart Failure With Preserved Ejection Fraction
    Mathew, Anna V., Seymour, E. Mitchell, Byun, Jaeman, Pennathur, Subramaniam, Hummel, Scott L. · 2015 · Journal of Cardiac Failure
  58. Rationale and Design of ENDEAVOR: A Sequential Phase 2b–3 Randomized Clinical Trial to Evaluate the Effect of Myeloperoxidase Inhibition on Symptoms and Exercise Capacity in Heart Failure with Preserved or Mildly Reduced Ejection Fraction
    Lars H. Lund, Carolyn S.P. Lam, Patricia Ely Pizzato, Anders Gabrielsen, Erik Michaëlsson, Karin Nelander, Hans Ericsson, Julie Holden, Folke Folkvaljon, Andrea Mattsson et al. · 2023 · European Journal of Heart Failure
  59. Effect of exercise training on post-translational and post-transcriptional regulation of titin stiffness in striated muscle of wild type and IG KO mice
    Carlos G. Hidalgo, Chandra Saripalli, Henk L. M. Granzier · 2014 · Archives of Biochemistry and Biophysics
  60. Soluble Neprilysin does not Correlate with Outcome in Heart Failure with Preserved Ejection Fraction
    Georg Goliasch, Noémi Pávó, Caroline Zotter‐Tufaro, Andreas Anselm Kammerlander, Franz Duca, Julia Mascherbauer, Diana Bonderman · 2016 · European Journal of Heart Failure
  61. Tensor Factorization for Precision Medicine in Heart Failure with Preserved Ejection Fraction
    Yuan Luo, Faraz S. Ahmad, Sanjiv Jayendra Shah · 2017 · Journal of Cardiovascular Translational Research
  62. Reduced Myocardial Flow Reserve Is Associated With Diastolic Dysfunction and Decreased Left Atrial Strain in Patients With Normal Ejection Fraction and Epicardial Perfusion
    Matthew C. Konerman, Joshua C. Greenberg, Theodore John Kolias, James R. Corbett, Ravi V. Shah, Venkatesh Locharla Murthy, Scott L. Hummel · 2017 · Journal of Cardiac Failure
  63. Effect of aerobic and resistance training on inflammatory markers in heart failure patients: systematic review and meta-analysis
    Melissa J. Pearson, Sean F. Mungovan, Neil A. Smart · 2018 · Heart Failure Reviews
  64. Perivascular fibrosis and the microvasculature of the heart. Still hidden secrets of pathophysiology?
    Kirsti Ytrehus B, Jean‐Sébastien Hulot, Cinzia Perrino, Gabriele G. Schiattarella, Rosalinda Madonna · 2018 · Vascular Pharmacology
  65. Abnormal skeletal muscle blood flow, contractile mechanics and fibre morphology in a rat model of obese‐HFpEF
    Ever Espino-González, Peter George Tickle, Alan P. Benson, Roger W. P. Kissane, Graham N. Askew, Stuart Egginton, Thomas Scott Bowen · 2020 · The Journal of Physiology
  66. Clinical Implications of Uric Acid in Heart Failure: A Comprehensive Review
    Marko Kumrić, Josip A. Borovac, Tina Tičinović Kurir, Joško Božić · 2021 · Life
  67. Visceral Adiposity, Muscle Composition, and Exercise Tolerance in Heart Failure with Preserved Ejection Fraction
    Wendy Ying, Kavita Sharma, Lisa R. Yanek, Dhananjay M. Vaidya, Michael Schär, Michael Markl, Vinita Subramanya, Sahar Soleimani, Pamela Ouyang, Erin D. Michos et al. · 2021 · ESC Heart Failure
  68. Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence
    Antoni Bayés‐Genís, Oriol Iborra Egea, Giosafat Spitaleri, Mar Domingo, Elena Revuelta‐López, Pau Codina, Germán Cediel, Evelyn Santiago‐Vacas, Adriana Cserkóová, Domingo Andrés Pascual-Figal et al. · 2021 · Scientific Reports
  69. Heart failure with preserved ejection fraction: Defining the function of ROS and NO
    Li Zuo, Chia‐Chen Chuang, Benjamin T. Hemmelgarn, Thomas Michael Best · 2015 · Journal of Applied Physiology
  70. Coronavirus 2019 Disease (COVID‐19), Systemic Inflammation, and Cardiovascular Disease
    Riccardo Maria Inciardi, Scott David Solomon, Paul M. Ridker, Marco Metra · 2020 · Journal of the American Heart Association
  71. Placenta-Derived Adherent Stromal Cells Improve Diabetes Mellitus-Associated Left Ventricular Diastolic Performance
    Sophie Van Linthout, Nazha Hamdani, Kapka Miteva, Annika Koschel, Irene Müller, Lena Pinzur, Zami Aberman, Kathleen Pappritz, Wolfgang Albrecht Linke, Carsten Tschöpe · 2017 · Stem Cells Translational Medicine
  72. Differences in Presentation, Diagnosis and Management of Heart Failure in Women. A Scientific Statement of the Heart Failure Association of the ESC
    Giuseppe M.C. Rosano, Davide Stolfo, Lisa Anderson, Magdy Abdelhamid, Marianna Adamo, Johann Bauersachs, Antoni Bayés‐Genís, Michael Böhm, Ovidiu Dragomir Chioncel, Gerasimos S Filippatos et al. · 2024 · European Journal of Heart Failure
  73. Hyperglycemia and angiotensin II cooperate to enhance collagen I deposition by cardiac fibroblasts through a ROS-STAT3-dependent mechanism
    Tania Fiaschi, Francesca Magherini, Tania Gamberi, Gianluca Lucchese, Giuseppe G. Faggian, Alessandra Modesti, Pietro Amedeo Modesti · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  74. Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction
    Parul U. Gandhi, Sheryl L. Chow, Thomas S. Rector, Henry Krum, Hanna Kim Gaggin, John J.V. McMurray, Michael R. Zile, Michel Komajda N, Robert Samuel McKelvie, Peter E. Carson et al. · 2016 · Journal of Cardiac Failure
  75. Cardiometabolic Syndrome and Increased Risk of Heart Failure
    Helene von Bibra, Walter Paulus, Martin St. John Sutton · 2016 · Current Heart Failure Reports
  76. Systolic Blood Pressure and Cardiovascular Outcomes in Heart Failure with Preserved Ejection Fraction: An Analysis of the TOPCAT trial
    Senthil Selvaraj, Brian Lee Claggett, Sanjiv Jayendra Shah, Inder S. Anand, Jean Lucien Rouleau, Akshay Suvas Desai, Eldrin Foster Lewis, Bertram Pitt, Nancy K. Sweitzer, Marc Alan Pfeffer et al. · 2017 · European Journal of Heart Failure
  77. Treatment of Heart Failure with Preserved Ejection Fraction
    Adriana Mihaela Ilieșiu, Andreea Simona Hodorogea · 2018 · Advances in experimental medicine and biology
  78. Early calcium handling imbalance in pressure overload-induced heart failure with nearly normal left ventricular ejection fraction
    Sarah Rouhana, Charlotte Farah, Jérôme Roy, Amanda Finan, Glaucy Rodrigues de Araújo, Patrice Bideaux, Valérie Scheuermann, Youakim Saliba, Cyril Reboul, Olivier Cazorla et al. · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  79. Long‐Term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow‐Up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging
    Anne S. Ersbøll, Annemie Stege Bojer, Maria Guldbrandt Hauge, Marianne Johansen, Peter Damm, Finn Gustafsson, Niels Grove Vejlstrup · 2018 · Journal of the American Heart Association
  80. The role of the kidney in acute and chronic heart failure
    Gaetano M. Ruocco, Alberto Palazzuoli, Jozine M. ter Maaten · 2019 · Heart Failure Reviews
  81. The impact of diastolic dysfunction as a predictor of cardiovascular events: A systematic review and meta-analysis
    Ricardo Ladeiras‐Lopes, Margarida Araújo, Francisco Sampaio, Adelino Ferreira Leite-Moreira, Ricardo Fontes‐Carvalho · 2019 · Revista Portuguesa de Cardiologia
  82. Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
    Alexandra Jichitu, SIMONA GABRIELA BUNGAU, Ana Maria Alexandra Stănescu, Cosmin Mihai Vesa, Mirela Mărioara Toma, Cristiana Bustea, Stela Iurciuc, Marius Rus, Nicolae Bacalbaşa, Camelia Cristina Diaconu · 2021 · Diagnostics
  83. Understanding Heart Failure With Mid-Range Ejection Fraction
    Carolyn S.P. Lam, Tiew‐Hwa Katherine Teng · 2016 · JACC Heart Failure
  84. Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction
    Francesco Tona, Roberta Montisci, Laura Iop, Giovanni Civieri · 2021 · Reviews in Cardiovascular Medicine
  85. Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms
    Johann K Bauersachs, Achim Lother · 2022 · Kidney International Supplements
  86. Obesity: The Perfect Storm for Heart Failure
    Maria Lembo, Teresa Strisciuglio, Celeste Fonderico, Costantino Mancusi, Raffaele Izzo, Valentina Trimarco, Alessandro Bellis, Emanuele Barbato, Giovanni Esposito, Carmine Morisco et al. · 2024 · ESC Heart Failure
  87. The Emerging Field of Cardioimmunology: Past, Present and Foreseeable Future
    Douglas L. Mann · 2024 · Circulation Research
  88. MicroRNAs in cardiovascular ageing
    Timon Seeger, Reinier Abraham Boon · 2015 · The Journal of Physiology
  89. Left Ventricular Diastolic Dysfunction in Ischemic Stroke: Functional and Vascular Outcomes
    Hong‐Kyun Park, Beom Joon Kim, Chang‐Hwan Yoon, Mi Yang, Moon‐Ku Han, Hee‐Joon Bae · 2016 · Journal of Stroke
  90. Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study
    May Bakir, Michael Douglas Nelson, Erika Jones, Quanlin Li, Janet Wei, Behzad Sharif, Margo Minissian, CHRISANDRA L. SHUFELT, George S. Sopko, Carl J. Pepine et al. · 2016 · International Journal of Cardiology
  91. Investigating a Biomarker-Driven Approach to Target Collagen Turnover in Diabetic Heart Failure with Preserved Ejection Fraction Patients. Effect of Torasemide Versus Furosemide on Serum C-Terminal Propeptide of Procollagen Type I (DROP-PIP trial)
    Tobias Daniel Trippel, Sophie Van Linthout, Dirk Westermann, Ruhdja Lindhorst, Anja Sandek, Stefanie Ernst, Anna Feuerstein, Mario Kašner, Frank Spillmann, Arantxa González et al. · 2017 · European Journal of Heart Failure
  92. Nitric oxide–sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fraction
    Nicola Wilck, Lajos Markó, András Balogh, Kristin Kräker, Florian Herse, Hendrik Bartolomaeus, István András Szijártó, Maik Gollasch, Nadine Reichhart, Olaf Strauß et al. · 2018 · JCI Insight
  93. Berberine, a Traditional Chinese Medicine, Reduces Inflammation in Adipose Tissue, Polarizes M2 Macrophages, and Increases Energy Expenditure in Mice Fed a High-Fat Diet
    Jiayu Lin, Qingyan Cai, Bo Liang, Lizhen Wu, Yong Zhuang, Yuanfang He, Wanrong Lin · 2019 · Medical Science Monitor
  94. Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction
    Bo Bai, Wulin Yang, Yanyun Fu, Hannah Lee Foon, Wan Ting Tay, Kangmin Yang, Cuiting Luo, Jayantha Gunaratne, Philip Lee, Michael R. Zile et al. · 2019 · JACC Basic to Translational Science
  95. Cellular Adhesion Molecules in Young Adulthood and Cardiac Function in Later Life
    Ravi B. Patel, Laura Anne Colangelo, Alex P. Reiner, Myron D. Gross, David R. Jacobs, Lenore J. Launer, João A.C. Lima, Donald M. Lloyd‐Jones, Sanjiv Jayendra Shah · 2020 · Journal of the American College of Cardiology
  96. Pathophysiology of Heart Failure with Preserved Ejection Fraction
    Youn, Jong-Chan, Ahn, Yuran, Jung, Hae Ok · 2021 · Heart Failure Clinics
  97. Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD
    João Pedro Ferreira, Francisco Vasques‐Nóvoa, Diana Ferrão, Francisca A. Saraiva, Inês Falcão‐Pires, João Sérgio Neves, Abhinav Sharma, Patrick Rossignol, Faiez M. Zannad, Adelino Ferreira Leite-Moreira · 2022 · Diabetes Care
  98. The Hippo-YAP pathway in various cardiovascular diseases: Focusing on the inflammatory response
    Ancheng Zheng, Qishan Chen, Li Zhang · 2022 · Frontiers in Immunology
  99. PCSK9: A emerging participant in heart failure
    Qian Xu, Yi-meng Zhao, Nai-qi He, Rong Gao, Wenxin Xu, Xiu-juan Zhuo, Zhong Ren, Chunyan Wu, Lushan Liu · 2022 · Biomedicine & Pharmacotherapy
  100. Coronary “Microvascular Dysfunction”: Evolving Understanding of Pathophysiology, Clinical Implications, and Potential Therapeutics
    Chun Yeung Kei, Kuljit Singh, Rustem F. Dautov, Thanh Ha Tuan Nguyen, Yuliy Y. Chirkov, John David Horowitz · 2023 · International Journal of Molecular Sciences